Page 7 - Morphic Holding News Today

Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) General Counsel William Devaul sold 3,802 shares of Morphic stock in a transaction dated Tuesday, May 23rd. The shares were sold at an average price of $60.03, for a total transaction of $228,234.06. Following the sale, the general counsel now owns 21,194 shares of the company’s stock, valued […]

BioPharma

Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) CAO Robert E. Farrell, Jr. sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 23rd. The shares were sold at an average price of $60.00, for a total transaction of $600,000.00. Following the transaction, the chief accounting officer now directly owns 23,708 […]

In this article, we will take a look at the 10 mid-cap stocks that insiders have been buying lately.

Several brokerages have updated their recommendations and price targets on shares of Morphic (NASDAQ: MORF) in the last few weeks: 5/8/2023 – Morphic was upgraded by analysts at TheStreet from a “d+” rating to a “c” rating. 4/26/2023 – Morphic had its price target raised by analysts at BMO Capital Markets from $83.00 to $106.00. […]

Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) Director Timothy A. Springer bought 1,050,000 shares of the firm’s stock in a transaction on Wednesday, May 3rd. The shares were purchased at an average price of $45.00 per share, for a total transaction of $47,250,000.00. Following the purchase, the director now owns 2,768,464 shares in the company, […]

SG Americas Securities LLC acquired a new position in Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) in the fourth quarter, HoldingsChannel reports. The fund acquired 19,023 shares of the company’s stock, valued at approximately $509,000. A number of other hedge funds also recently added to or reduced their stakes in MORF. Credit Suisse AG raised […]

Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) shares traded up 5.8% on Monday . The company traded as high as $50.23 and last traded at $50.01. 130,142 shares traded hands during mid-day trading, a decline of 72% from the average session volume of 457,732 shares. The stock had previously closed at $47.26. Analyst Upgrades and […]

Shares of Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) saw unusually-high trading volume on Wednesday . Approximately 732,012 shares traded hands during mid-day trading, an increase of 56% from the previous session’s volume of 469,112 shares.The stock last traded at $50.96 and had previously closed at $48.49. Analysts Set New Price Targets MORF has been […]

WALTHAM, Mass., May 02, 2023 -- Morphic Holding, Inc. , a biopharmaceutical company developing a portfolio of oral integrin therapies for the treatment of serious chronic diseases, today announced... | May 2, 2023